R13 (药物)

化合物

R13是一种小分子黄酮类化合物药物,可口服给药[1],是脑源性神经营养因子受体——Trk受体B(TrkB)的选择性激动剂,用于阿兹海默症的治疗[2]

R13
临床资料
其他名称4-Oxo-2-phenyl-4H-chromene-7,8-diyl bis(methylcarbamate)
给药途径口服给药[1]
药物动力学数据
代谢产物7,8-二羟基黄酮[1]
识别信息
  • [8-(Methylcarbamoyloxy)-4-oxo-2-phenylchromen-7-yl] N-methylcarbamate
CAS号1609067-49-3  checkY
PubChem CID
UNII
化学信息
化学式C19H16N2O6
摩尔质量368.35 g·mol−1
3D模型(JSmol英语JSmol
  • CNC(=O)OC1=C(C2=C(C=C1)C(=O)C=C(O2)C3=CC=CC=C3)OC(=O)NC
  • InChI=1S/C19H16N2O6/c1-20-18(23)26-14-9-8-12-13(22)10-15(11-6-4-3-5-7-11)25-16(12)17(14)27-19(24)21-2/h3-10H,1-2H3,(H,20,23)(H,21,24)
  • Key:NWWRHMSYZTWUBD-UHFFFAOYSA-N

参考文献

编辑
  1. ^ 1.0 1.1 1.2 Chen C, Wang Z, Zhang Z, Liu X, Kang SS, Zhang Y, Ye K. The prodrug of 7,8-dihydroxyflavone development and therapeutic efficacy for treating Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. January 2018, 115 (3): 578–583. PMC 5777001 . PMID 29295929. doi:10.1073/pnas.1718683115 . 
  2. ^ US application 20150274692,Keqiang Ye,“7,8-Dihydoxyflavone and 7,8-substituted flavone derivatives, compositions, and methods related thereto”,发表于2015-10-01,指定于Emory University 

外部链接

编辑